Status:
COMPLETED
Effects of Water and Food Intake on the Pharmacokinetics and Pharmacodynamics of Oral Salmon Calcitonin in Healthy Postmenopausal Women
Lead Sponsor:
Novartis
Conditions:
Postmenopausal Osteoporosis
Eligibility:
FEMALE
40-70 years
Phase:
PHASE1
Brief Summary
This is a phase I study to analyze the effect of water and food intake on the bioavailability and pharmacodynamic of oral salmon calcitonin (SMC021) and salmon calcitonin nasal spray in post-menopausa...
Eligibility Criteria
Inclusion
- Healthy postmenopausal women
Exclusion
- Previous treatment with other osteoporosis medication
- Other protocol defined inclusion/exclusion criteria may apply.
Key Trial Info
Start Date :
October 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT00395395
Start Date
October 1 2006
Last Update
May 28 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Multiple Cities, Denmark